Multicenter, Open, Non-randomized 6 Months Study to Evaluate Efficacy and Safety Insuman Basal, Insuman Comb 25, Insuman Rapid in Insulin-naive Patients With T2DM Who Received Baseline Education Course in the Diabetes School.
Phase of Trial: Phase IV
Latest Information Update: 02 Jul 2014
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SPIRIT
- Sponsors Sanofi
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Mar 2013 Planned number of patients changed from 550 to 558 as reported by ClinicalTrials.gov.
- 28 Mar 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.